Table I.
Correlations between glycocalyx components and inflammatory cytokines and coagulation/fibrinolysis markers.
| HPA | HS | SDC-1 | ||||
|---|---|---|---|---|---|---|
| rho | P-value | rho | P-value | rho | P-value | |
| Inflammatory cytokines | ||||||
| TNF-α | 0.94 | <0.001 | 0.95 | <0.001 | 0.47 | 0.066 |
| IL-6 | 0.83 | <0.001 | 0.47 | 0.066 | 0.72 | 0.002 |
| Coagulation/fibrinolysis markers | ||||||
| F1+2 | 0.92 | <0.001 | 0.88 | <0.001 | 0.45 | 0.08 |
| TAT | 0.238 | 0.374 | 0.28 | 0.284 | 0.61 | 0.012 |
| AT | −0.847 | <0.001 | −0.78 | <0.001 | −0.447 | 0.083 |
| PAI-1 | 0.918 | <0.001 | 0.79 | <0.001 | 0.294 | 0.269 |
HPA, heparanase; HS, heparan sulfate; SDC-1, syndecan-1; TNF-α, tumor necrosis factor-α; IL-6, interleukin-6; F1+2, prothrombin fragment 1+2; TAT, thrombin-antithrombin complex; AT, antithrombin; PAI-1, plasminogen activator inhibitor-1. Correlations between HPA, HS, SDC-1 and TNF-α, IL-6, F1+2, TAT, AT-III and PAI-1 were assessed by using the Spearman rank test.